News About: Pharm. Industry
Mr. Hyeon Dong-wook nominated CEO of Baxter Korea.Mr. Hyeon Dong-wook, the former president of Metronic Korea, was nominated the CEO of Baxter Korea, a bio-tech company as of Aug. 2.
He studied at California University majo...
|
50 leading OTC products analyzed
The combined market share of Korea's 50 leading OTC drugs for the fist six months accounted for 37.58 percent, up 36.95 percent in January, and SK Pharm's Trast patch 48mg had the highest cumulative six-month ...
Industries looking for best PPA substitutes.
The yearly 300 billion won size of the cold remedy markets seemed to be rapidly transformed with other alternatives contained non-PPA ingredients like pseudo-ephedrin and herbal preparations, especially the combined r...
PPA-containing medicines ban having little impact to six Korea drug makers in Korea Stock Exchange
Overall, the share prices of six pharmaceutical firms producing phenylpropanolamine (PPA) based cold remedies showed little sign of plunge between July 30 to August 5, despite the recent jitters over PPA drugs...
Domestic cold remedy makers rushing to recall PPA-containing preparations
With the recent announcement of the Korea Food and Drug Administration that it has banned production and sales of 167 cough and cold remedies containing phenylpropanolamine (PPA), an ingredient that may cause hemorrha...
Sales of PPA drugs may little impact to industries.
The recent scandals on cold remedies containing PPA (phenylpropanolamine) may not give any serious impact to the total sales of drug companies according to an analysis of Hanyang Security Co.
The analysis indicat...
Famciclovir patent dispute in Korea
Novaris's Korean subsidiary, Novartis Korea, has initiated legal action against Kyungdong Pharm, which is commercializing generic version of its antiviral agent, Famvir (famciclovir). The suit, which was filed to the ...
Stiefel Korea's Stieva-A cream acquires additional indication for treatment of photoaging
Stiefel Korea has received from the Korea Food and Drug Administration an additional approval for its anti-acne cream, Stieva-A cream (trentinoin) for the first time in Korea, as a treatment to assist in reducing cert...
Diabetic care and assessed by health economic approach.
Under the circumstances of rapidly rising diabetics as a result of the life style changes and the entry of aging society, it is pointed out by many experts that a health economic approach may suggest a way to prevent...
SK Chemical to agree exclusive distribution of TMX-67.
SK Chemical and SK pharmaceutical division made a technical licence agreement with Japanese Deijin on July 13 for an exclusive distribution of TMX-67 (febuxostat) in Korea, a new compound for the treatment of gout, th...
